HealthEquity (HQY) Investor Update summary

CEO succession announcement and transition

• CEO Jon Kessler will retire effective January 6, 2025, with Scott Cutler named as his successor and joining the board on that date.

• Kessler will remain as director and special advisor through April 30, 2025, to support the transition.

• The succession process was planned over several years, with a focus on CEO experience, growth track record, and cultural fit.

• The board and management emphasized the company's strong position, stability, and readiness for leadership change.

• The announcement was timed to coincide with readiness and Scott Cutler's transition from StockX.

Incoming CEO background and strategic fit

• Scott Cutler brings experience from NYSE Euronext, StubHub, eBay, and StockX, with a focus on technology, partnerships, and growth.

• His expertise in B2B and B2C marketplaces aligns with the company's strategy of technology-driven consumer empowerment.

• The board prioritized complementary skills over direct healthcare experience, seeking execution and innovation.

• Cutler is expected to enhance consumer engagement and drive further innovation in product and partnership development.

Strategic direction and ongoing initiatives

• The company is expanding HSA fee streams, launching new products like Health Payment Accounts, and enhancing benefits engagement offerings.

• Focus remains on empowering healthcare consumers, deepening partnerships, and leveraging technology for operational efficiency.

• Ongoing initiatives include AI-driven customer experience, digitizing the sales funnel, and tailored incentive platforms.

• The leadership team is positioned for innovation-driven growth, moving beyond integration of acquisitions.